Financhill
Sell
35

RMD Quote, Financials, Valuation and Earnings

Last price:
$216.48
Seasonality move :
6.91%
Day range:
$201.84 - $216.60
52-week range:
$172.19 - $263.05
Dividend yield:
1.01%
P/E ratio:
24.15x
P/S ratio:
6.12x
P/B ratio:
5.72x
Volume:
1.5M
Avg. volume:
1M
1-year change:
8.94%
Market cap:
$30B
Revenue:
$4.7B
EPS (TTM):
$8.47

Earnings Data

Next earnings date for RMD
Apr 23
2025
Most recent earnings per share
$2.34
Beat by $0.03
(Jan 30/2025)
Consensus Estimate
$2.31
(Jan 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RMD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $1.3B -- -- $2.45 --
04/23/2025 Q1 $1.3B -- -- $2.36 --
01/30/2025 Q4 $1.3B $1.3B $2.34 $2.31 $0.03
10/24/2024 Q3 $1.2B $1.2B $2.11 $2.04 $0.07
08/01/2024 Q2 $1.2B $1.2B $1.98 $2.07 -$0.09
04/25/2024 Q1 $1.2B $1.2B $2.04 $1.91 $0.13
01/24/2024 Q4 $1.2B $1.2B $1.42 $1.78 -$0.36
10/26/2023 Q3 -- -- $1.49 $1.61 -$0.12
08/03/2023 Q2 -- -- $1.56 $1.69 -$0.13
04/27/2023 Q1 -- -- $1.58 $1.59 -$0.01
01/26/2023 Q4 -- -- $1.53 $1.62 -$0.09
10/27/2022 Q3 -- -- $1.43 $1.60 -$0.17
08/11/2022 Q2 -- -- $1.33 $1.46 -$0.13
04/28/2022 Q1 -- -- $1.22 $1.44 -$0.22
01/27/2022 Q4 -- -- $1.37 $1.52 -$0.15
10/28/2021 Q3 -- -- $1.39 $1.35 $0.04
08/05/2021 Q2 -- -- $1.33 $1.29 $0.04
04/29/2021 Q1 -- -- -$0.54 $1.27 -$1.81
01/28/2021 Q4 -- -- $1.23 $1.28 -$0.05
10/29/2020 Q3 -- -- $1.22 $1.03 $0.19
08/05/2020 Q2 -- -- $1.22 $1.07 $0.15
04/30/2020 Q1 -- -- $1.12 $1.08 $0.04
01/30/2020 Q4 -- -- $1.10 $1.03 $0.07
10/24/2019 Q3 -- -- $0.83 $0.87 -$0.04
07/25/2019 Q2 -- -- $0.48 $0.92 -$0.44
05/02/2019 Q1 -- -- $0.73 $0.85 -$0.12
01/24/2019 Q4 -- -- $0.86 $0.95 -$0.09
10/25/2018 Q3 -- -- $0.73 $0.79 -$0.06
08/02/2018 Q2 -- -- $0.76 $0.93 -$0.17
04/26/2018 Q1 -- -- $0.76 -- --
01/22/2018 Q4 -- -- $0.07 -- --
10/26/2017 Q3 -- -- $0.60 -- --
08/01/2017 Q2 -- -- $0.71 -- --
04/27/2017 Q1 -- -- $0.62 -- --
01/23/2017 Q4 -- -- $0.54 -- --
10/25/2016 Q3 -- -- $0.54 -- --
07/28/2016 Q2 -- -- $0.59 -- --
04/26/2016 Q1 -- -- $0.64 -- --
01/21/2016 Q4 -- -- $0.68 -- --
10/22/2015 Q3 -- -- $0.58 -- --
07/30/2015 Q2 -- -- $0.61 -- --

ResMed Earnings Questions

  • How Much did ResMed Generate in Revenue Last Quarter?

    ResMed reported $1.3B worth of top line sales in its most recent quarter.

  • Did ResMed Beat Earnings Last Quarter?

    ResMed announced earnings per share of $2.34 which represents a beat of analyst forecast a $2.31 per share.

  • Is ResMed Profitable?

    ResMed reported $751.3M that represents $5.09 per share over the last quarter.

  • What is the Analyst Consensus for ResMed EPS Next Year?

    ResMed's earnings are forecast to grow from $6.92 per share to $7.70 per share next year representing an increase of 36.83%.

  • When is ResMed's Earnings Date?

    ResMed's next earnings date is April 23, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Archer Aviation a Buy, Sell or Hold?
Is Archer Aviation a Buy, Sell or Hold?

Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…

Down 50%, Is Dell Technologies a Buy?
Down 50%, Is Dell Technologies a Buy?

Dell (NYSE:DELL)’s share price has been on a roller coaster…

How Bad Will the Stock Market Get?
How Bad Will the Stock Market Get?

In recent trading days, global stock markets have seen massive…

Stock Ideas

Sell
36
Is MSFT Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 30x

Sell
30
Is AAPL Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 28x

Sell
33
Is NVDA Stock a Buy?

Market Cap: $2.3T
P/E Ratio: 33x

Alerts

Sell
28
PRKS alert for Apr 9

United Parks & Resorts [PRKS] is up 15.37% over the past day.

Buy
55
SLNO alert for Apr 9

Soleno Therapeutics [SLNO] is up 7.3% over the past day.

Sell
20
HELE alert for Apr 9

Helen Of Troy [HELE] is up 10.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock